Clinical Analysis: 16-Year-Old Male with Delayed Puberty

Step 1 — Synthesize the Clinical Picture

Step 2 — Diagnostic Interpretation

1. Constitutional Delay of Growth and Puberty (CDGP) — most likely

• Low testosterone + low gonadotropins + delayed bone age with no epiphyseal fusion = CDGP hallmarks
• Presence of Adams apple = some virilization has begun, consistent with early/late CDGP
• Bone age 13–14 with open epiphyses = growth potential remains, consistent with late maturer
• Normal MRI pituitary, normal prolactin, TTG negative (celiac ruled out)
• Family history of late puberty in a parent is classically present
• CDGP is a diagnosis of exclusion — must rule out congenital hypogonadotropic hypogonadism (CHH)

2. Congenital Hypogonadotropic Hypogonadism (CHH/Kallmann syndrome)

• Cannot be distinguished from CDGP on baseline labs alone — both show low T + low LH/FSH
• CHH red flags (absent here): anosmia (Kallmann), cryptorchidism, micropenis from birth, no Adams apple at all, no spontaneous pubertal signs whatsoever
• The Adams apple present here slightly favors CDGP over CHH, but not definitively

3. Functional Hypogonadotropic Hypogonadism

• Severe underweight (34 kg at 16 years) + poor nutrition + possible psychological/eating disorder stress can suppress the GnRH pulse generator
• This is a strong contributor and partially reversible with nutritional rehabilitation
• Irregular bowel + low weight: consider inflammatory bowel disease, though TTG-IgA negative rules out celiac

Cortisol consideration:

• Basal 8 AM cortisol of 11.08 µg/dL is borderline low. Normal cortisol response to stimulation (>18 µg/dL at 30–60 min post ACTH) should be confirmed. Mild adrenal insufficiency can compound poor growth and weight gain.

Step 3 — Additional Investigations Needed Now

1. GnRH stimulation test (or GnRH analogue test) — Administer GnRH 100 µg IV; measure LH and FSH at 0, 30, 60 min. A robust LH surge favors an intact pituitary (CDGP); blunted response seen in both CHH and CDGP, so not fully diagnostic alone.
2. hCG stimulation test — Administer hCG IM for 3 days; measure testosterone before and after. A rise in testosterone confirms functional Leydig cells (supports CDGP or functional delay).
3. Inhibin B — Low inhibin B (<35 pg/mL) suggests CHH rather than CDGP; normal inhibin B favors CDGP.
4. SHBG (Sex Hormone Binding Globulin) — Low SHBG in context of low free T may indicate nutritional/hepatic status.
5. ACTH stimulation test (Synacthen test) — Given borderline 8 AM cortisol (11 µg/dL), confirm adrenal reserve. If cortisol <18 µg/dL at 60 min post ACTH, treat as adrenal insufficiency.
6. IGF-1 and IGFBP-3 — GH of 0.092 ng/mL is a random value and physiologically useless alone (GH is pulsatile). IGF-1 (stable, reflects average GH secretion) will tell you whether GH deficiency is present. If IGF-1 is low, proceed to GH stimulation test (e.g., insulin tolerance test or glucagon stimulation test).
7. Thyroid function (TSH, Free T4) — Hypothyroidism causes delayed puberty, poor growth, and weight gain failure.
8. Full blood count, ESR/CRP, albumin, LFTs, iron studies — Rule out chronic inflammatory disease (IBD), malnutrition, iron deficiency.
9. Karyotype — Rule out Klinefelter syndrome (47,XXY), which classically presents at puberty with small firm testes, gynecomastia, and tall stature, though testes here are described as small. Klinefelter would show elevated FSH/LH (primary hypogonadism), which is NOT the pattern here, so low priority but completeness warrants it if CHH is being worked up.
10. Olfactory assessment — Ask specifically about sense of smell. Anosmia/hyposmia + hypogonadotropic hypogonadism = Kallmann syndrome.

Step 4 — Management

A. Treat nutritional deficiency

• 34 kg at 16 is severe underweight. Structured nutritional support and dietitian referral. Identify and treat any underlying GI disorder causing malabsorption (despite negative TTG, consider small bowel evaluation if diarrhea predominates).
• Nutritional rehabilitation alone may restore the GnRH pulse generator and allow puberty to proceed spontaneously.

B. Psychological support

• Depression in pubertal delay is reactive and real. Provide counseling/psychiatric evaluation. Explain the diagnosis reassuringly — if CDGP, puberty will occur.

C. Testosterone therapy (to induce puberty and psychological relief)

• In adolescent boys with CDGP, low-dose testosterone is safe and does not compromise final adult height when bone age is monitored:
  • Testosterone enanthate 50 mg IM every 4 weeks for 3–6 months (short course)
  • This is sufficient to trigger virilization (pubic hair growth, penile enlargement, psychosocial improvement) while preserving bone growth potential
  • Reassess: if puberty progresses spontaneously after stopping = CDGP confirmed
  • If puberty stalls after stopping = suggests CHH; then requires long-term testosterone replacement or pulsatile GnRH therapy
• Do NOT use full adult replacement doses (testosterone enanthate 200–250 mg/4 weeks) at this stage — excessive androgens accelerate bone age and compromise adult height (bone age already delayed 2–3 years = significant height potential remains)

D. Bone age follow-up

• Repeat wrist X-ray every 6 months during therapy to monitor epiphyseal status and growth velocity.

E. GH deficiency management

• If IGF-1 is confirmed low and GH stimulation test confirms GH deficiency, recombinant human GH (rhGH) injections are indicated. This is important — untreated GH deficiency will compound pubertal delay and stunt final height.

F. Adrenal insufficiency

• If ACTH stimulation test confirms adrenal insufficiency, initiate hydrocortisone replacement before any other hormonal treatment (glucocorticoids are physiologically upstream).

Step 5 — Most Likely Diagnosis

• Primary diagnosis: Constitutional Delay of Growth and Puberty (CDGP) — supported by the hypogonadotropic pattern, open epiphyses, delayed bone age, absent structural pituitary pathology, and the presence of some androgenization (Adams apple)
• Contributing factor: Functional hypogonadotropic hypogonadism due to severe undernutrition — 34 kg at 16 years is a major contributor
• Differential that must be excluded: Congenital hypogonadotropic hypogonadism (CHH) — cannot distinguish from CDGP without stimulation tests, inhibin B, and longitudinal observation
• Absent adrenarche (no pubic/axillary hair) despite Adams apple is unusual — adrenarche is adrenal-driven and independent of the HPG axis. This combination raises the possibility of adrenal insufficiency contributing to the absent adrenarche. The borderline cortisol supports this.

Summary Action Plan

Diagnosis & Management — 16M with Delayed Puberty

Working Diagnosis

Why This Pattern?

Investigations to Order Now (in priority order)

1. TSH + Free T4 — hypothyroidism mimics this entire picture
2. IGF-1 + IGFBP-3 — screens for GH deficiency (random GH is meaningless)
3. Inhibin B — low (<35 pg/mL) favors CHH over CDGP
4. ACTH stimulation test (Synacthen 250 µg IV) — confirm adrenal reserve given borderline cortisol and absent adrenarche
5. GnRH stimulation test — IV GnRH 100 µg → LH/FSH at 0, 30, 60 min (helps differentiate pituitary vs hypothalamic cause, though cannot reliably separate CDGP from CHH)
6. hCG stimulation test — hCG IM × 3 days → testosterone rise confirms intact Leydig cell function
7. SHBG, albumin, CBC, ESR/CRP, iron studies — nutritional status + chronic inflammation screen
8. Olfactory testing — Ask directly about sense of smell; anosmia = Kallmann syndrome
9. If GH deficiency confirmed on IGF-1: formal GH stimulation test (glucagon or insulin tolerance)
10. Karyotype — low priority here (FSH/LH not elevated, so Klinefelter unlikely), but order if CHH workup is pursued

Treatment

• Testosterone enanthate 50 mg IM every 4 weeks × 3–6 months
• This dose is sufficient to begin virilization (pubic hair, penile growth, mood improvement) without accelerating bone age or compromising final adult height
• After stopping the course, observe for 6 months: spontaneous pubertal progression = CDGP confirmed; stall = suggests CHH requiring long-term treatment

Monitoring

• Bone age X-ray every 6 months during testosterone therapy
• Track growth velocity, pubertal staging (Tanner), weight gain
• Reassess LH, FSH, testosterone after completing testosterone course to determine if HPG axis has awakened spontaneously